Optimal Platelet Dose Strategy for Management of Thrombocytopenia

PHASE3CompletedINTERVENTIONAL
Enrollment

1,351

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Thrombocytopenia
Interventions
PROCEDURE

Medium Dose Prophylactic Platelet Transfusions

2.2 x 10\^11 platelets per m\^2 BSA

PROCEDURE

Lower Dose Prophylactic Platelet Transfusions

1.1 x 10\^11 platelets per m\^2 BSA

PROCEDURE

Higher Dose Prophylactic Platelet Transfusions

4.4 \* 10\^11 platelets per m\^2 BSA

Trial Locations (21)

10021

NY-Presbyterian Hosp/Weill Cornell Medical Center, New York

15213

University of Pittsburgh Presbyterian and Shadyside Hospital, Pittsburgh

19104

U of Pennsylvania Health System; Children's Hospital of Philadelphia, Philadelphia

21201

University of Maryland Medical Center, Baltimore

21287

Johns Hopkins Hospital, Baltimore

27514

University of North Carolina Hospitals, Chapel Hill

27710

Duke University Medical Center, Durham

30322

Emory University Hospitals; Children's Healthcare of Atlanta, Atlanta

44106

University Hospital Cleveland, Cleveland

52242

University of Iowa Hospitals and Clinics, Iowa City

53201

University of Wisconsin Hospital and Clinics, Madison

Children's Hospital of Wisconsin, Milwaukee

53215

Oncology Alliance/St. Luke's Hospital, Milwaukee

53226

Froedtert Memorial Lutheran Hospital, Milwaukee

55455

University of Minnesota Medical Center, Fairview, Minneapolis

70112

Tulane University Hospital and Clinics, New Orleans

73104

U of Oklahoma Health Sciences Center, Oklahoma City

75390

U of Texas SW Medical Center at Dallas, Dallas

98101

Virginia Mason Hospital, Seattle

98104

U of Washington Medical Center/FHCRC; Children's Hospital and Medical Center, Seattle

02115

Children's Hospital Boston; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Transfusion Medicine/Hemostasis Clinical Research Network

NETWORK

lead

Carelon Research

OTHER